Strategic merger Pattern Health merged with Greenlight Health Data Solutions in December 2024, expanding its data capabilities and market reach. This presents cross-sell opportunities to customers of both entities and potential to upsell advanced integration services and broader trial platforms.

Clinical trial platform The company provides a no-code platform with data collection, digital interventions, and outcomes cataloging for academic researchers, CROs, and biopharma. This creates opportunities to upsell more complex study modules, larger participant cohorts, and expanded digital health programs to current customers.

Targeted clinical apps Recent and ongoing app development like the EMPOWER app for ILD patients indicates a capability to commercialize disease-specific digital health solutions. Sales potential exists in offering ready-to-deploy apps or white-label variants to health systems and research partners.

Home-based care Past launches such as home-based cardiac rehab demonstrate a track record in remote patient monitoring and at-home interventions. This aligns with payer and provider interest in scalable remote programs, suggesting opportunities to pitch end-to-end remote trial and care pathways.

Growth potential With a modest revenue range and 머 funding, Pattern Health shows room for expansion through larger biopharma collaborations, expanded cloud-based data services, and deeper integration with cloud and marketing ecosystems. Align outreach around scalable deployment, enterprise-grade support, and referenceable outcomes.